Your browser doesn't support javascript.
loading
Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.
Liu, Fangbing; Zhao, Qiushi; Su, Yongwei; Lv, Jing; Gai, Yuqing; Liu, Shuang; Lin, Hai; Wang, Yue; Wang, Guan.
Afiliación
  • Liu F; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Zhao Q; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Su Y; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Lv J; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Gai Y; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Liu S; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.
  • Lin H; Department of Hematology and Oncology, First Hospital of Jilin University, Changchun, China.
  • Wang Y; Department of Pediatric Hematology and Oncology, First Hospital of Jilin University, Changchun, China. Electronic address: wang_yue@jlu.edu.cn.
  • Wang G; National Engineering Laboratory for AIDS Vaccine, Key Laboratory for Molecular Enzymology and Engineering, Ministry of Education, School of Life Sciences, Jilin University, Changchun, China;. Electronic address: wg10@jlu.edu.cn.
Exp Hematol ; 105: 39-49, 2022 01.
Article en En | MEDLINE | ID: mdl-34767916
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Tiofenos / Leucemia Mieloide Aguda / Resistencia a Antineoplásicos / Compuestos Bicíclicos Heterocíclicos con Puentes / Citarabina / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Exp Hematol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Tiofenos / Leucemia Mieloide Aguda / Resistencia a Antineoplásicos / Compuestos Bicíclicos Heterocíclicos con Puentes / Citarabina / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Exp Hematol Año: 2022 Tipo del documento: Article País de afiliación: China